Psychedelic

Psychedelics are drugs which alter the perception, causing a number of mental effects which manifest in many forms including altered states of consciousness, visual or tactile effects.

Read more on TripSit Wiki...
NameCategoriesSummary
1P-ETH-LADpsychedelictentativeresearch chemicalA new psychedelic lysergamide which is suspected to be a prodrug of ETH-LAD, which could explain why the doses are very similar. Or it could be active on its own. Scientific studies would need to be written to understand, yet there are none.
1P-LSDpsychedelicresearch chemicalAn LSD analogue which appears to be slightly more potent with a shorter duration. Its effects are reported to be extremely similar to LSD, and thus far seems to be similarly safe. Released in late 2014, It has quickly become a highly popular research chemical due to its implicit legality, similarity to LSD and wide availability on the Internet.
2-Me-DMTpsychedelicresearch chemicaltentativeAlso known as 2,N,N-TMT, this drug was first synthesised by Alexander Shulgin. Described as a very mild psychedelic of similar subjective effects to other tryptamines. Reported as having an unusual and unpredictable dose curve, it is recommended to start low with this drug.
25B-NBOHpsychedelicresearch chemicaltentativeA phenethylamine">Phenethylamine psychedelic and stimulant derivative of 2C-B, this compound is related to and has similar effects to 25B-NBOMe. It is significantly more potent than 2C-B but less potent than 25B-NBOMe. Overdoses of NBOH compounds may cause dangerous vasoconstriction. May induce uncomfortable body load.
25B-NBOMepsychedelicresearch chemicalPsychedelic phenethylamine">Phenethylamine, active in the lower microgram range, that is not active orally.
25C-NBOHpsychedelicresearch chemicaltentativeA phenethylamine">Phenethylamine psychedelic and stimulant derivative of 2C-C, this compound is related and has similar effects to 25C-NBOMe. It is significantly more potent than 2C-C but less potent than 25C-NBOMe. Overdoses of NBOH compounds may cause dangerous vasoconstriction. May induce uncomfortable body load.
25C-NBOMepsychedelicresearch chemicalcommonA relatively new and popular research chemical. A short acting psychedelic related to 2C-C with similar effects to LSD, though more visual with less of a 'head-trip.' Frequently mis-sold as LSD. Causes an uncomfortable body load and has caused several deaths even within regular dose ranges.
25D-NBOMepsychedelicresearch chemicalUncommon analogue of 2C-D. Extremely potent psychedelic with stimulating qualities. Could cause dangerous vasoconstriction at high doses. May induce uncomfortable body load.
25E-NBOMepsychedelicresearch chemicalA potent psychedelic phenethylamine">Phenethylamine and derivative of 2C-E, usually sold on blotters. May be mis-sold as LSD. Effects include vivid hallucinations, stimulation, heavy body load and vasoconstriction. At high doses vasoconstriction can endanger life, exercise caution.
25G-NBOMepsychedelicresearch chemicaltentativeA rare psychedelic stimulant and bomamine. A derivative of 2C-G, but far more potent. Likely to have hallucinogenic, stimulant and vasoconstrictive properties which may be dangerous at high doses. A heavy body load is to be expected.
25H-NBOMepsychedelicresearch chemicaltentativeA rare psychedelic stimulant and bomamine. A derivative of 2C-H, but many times more potent. Likely to have hallucinogenic, stimulant and vasoconstrictive properties which may be dangerous at high doses. A heavy body load is to be expected.
25I-NBFtentativepsychedelicresearch chemicalIs a derivate of the psychedelic 2C-I. Was sold breifly in a few countries before being banned. Based purely on the pharmacological evidence it'll be between 6-8x less potent than it's parent compound 25I-NBOMe.
25I-NBMDpsychedelicresearch chemicaltentativeA psychedelic phenethylamine">Phenethylamine that is related to the 25X-NBOMe series which in turn makes it related to the 2C-X series. Quite potent substance.
25I-NBOHpsychedelicresearch chemicaltentativeA phenethylamine">Phenethylamine psychedelic and stimulant derivative of 2C-I, this compound is related and has similar effects to 25I-NBOMe. It is significantly more potent than 2C-I but less potent than 25I-NBOMe. Overdoses of NBOH compounds may cause dangerous vasoconstriction. May induce uncomfortable body load.
25I-NBOMepsychedelicresearch chemicalcommonA relatively new and popular research chemical with psychedelic properties. Users report an uncomfortable body load with very strong visuals, though with less of a mental aspect than most psychedelics. Commonly mis-sold as LSD, since it is much cheaper to produce. Is considered quite unsafe, and has caused several deaths at 'regular' doses.
25iP-NBOMepsychedelicresearch chemicaltentativeAlmost unheard-of bomamine analogue of 2C-IP. Extremely potent psychedelic with stimulating qualities. May cause potentially dangerous vasoconstriction at high doses. May induce uncomfortable body load.
25N-NBOMepsychedelicresearch chemicaltentativeA rare, highly potent and yellow psychedelic phenethylamine">Phenethylamine and derivative of 2C-N. Effects are similar to other NBOMe compounds, with hallucinations, intense body load, stimulation and vasoconstriction. At high doses vasoconstriction can be dangerous, exercise caution.
25P-NBOMepsychedelicresearch chemicaltentativeA rare potent psychedelic drug with similar effects and risks to others in the NBOMe class. Yet no trip reports... when the substance was first sold in mid-late 2012, and resurfaced in early 2015.
25T-2-NBOMepsychedelicresearch chemicaltentativeA potent serotonin receptor agonist at the 5-HT2a receptor that is of the NBOMe drug class. It is a hallucinogenic and psychedelic with limited recorded human use.
25T-4-NBOMetentativepsychedelicresearch chemicalA psychedelic RC of the NBOMe class of drugs that is expected to cause hallucinations. Limited human use has been recorded on this drug and caution should be used with dosing.
2C-BpsychedelicempathogencommonA popular psychedelic in the phenethylamine">Phenethylamine family. Provides empathic experiences at lower doses and strong visual and psychedelic experiences at higher doses. Commonly used as a party drug as it is more clear-headed than most psychedelics. 2C-B has been in use since the early 1990s
2C-B-ANpsychedelictentativeresearch chemical2C-B-AN is a novel prodrug for 2C-B.
2C-B-FLYpsychedelicresearch chemicalPsychedelic phenethylamine">Phenethylamine that is the dihydrodifuran analog of 2C-B.
2C-Cpsychedelicresearch chemicalA short-acting psychedelic research chemical of the 2c-x family. Often described as being less stimulating than the other 2c-x, and is a relatively unique psychedelic in this respect.
2C-Dpsychedelicresearch chemicalA fairly generic psychedelic famed for being usable as "psychedelic tofu". Little character of its own but pleasant in combinations.
2C-Epsychedelicresearch chemicalcommonAn intense psychedelic drug with very strong visuals, sometimes criticised for its relatively uncomfortable body load. Otherwise, effects are comparable to other 2c-x drugs.
2C-Gpsychedelicresearch chemicaltentativeExtremely rare drug of the 2C-X family. An extremely long lasting substance. Is nearly as potent as its Amphetamine counter-part, Ganesha. Yet is said to have very little visual activity.
2C-Ipsychedelicresearch chemicalA psychedelic similar to the more well-known 2C-B. Users frequently report very vivid and bright open-eye visuals and more mild closed-eye visuals compared to 2C-B and other drugs in the 2C family. Can also be more stimulating than 2C-B along with having a slight body load for some users. Less safe at high doses compared to 2C-B
2C-IPpsychedelicresearch chemicaltentativeIsopropyl analog (branched analog) of 2C-P with a slightly shorter duration and lower potency.
2C-Npsychedelicresearch chemicaltentativeA relatively uncommon and short-acting psychedelic phenethylamine">Phenethylamine of the 2C-x family. It behaves much like other 2C-x drugs, but is unique in that it is a yellow-coloured salt. Described by some, including Shulgin, as being rather underwhelming.
2C-Ppsychedelicresearch chemicalA synthetic phenylethlyamine that is sometimes compared in effects to 2C-E, yet with a much longer duration. With a much more pronouced bodyload. Is one of the most potent of the 2C-X series.
2C-Tpsychedelicempathogenresearch chemicaltentativeA very rare psychedelic phenylethylamine, that is quite lovely.
2C-T-2psychedelicresearch chemicalAn unusual psychedelic with similar effects to 2C-B and a slightly longer duration, but maligned because of some deaths in the 2000s. Also similar to 2C-T-7, but with a shorter duration. Potentially unsafe with stimulants and empathogens.
2C-T-21psychedelicresearch chemicaltentativeA rare psychedelic phenethylamine">Phenethylamine.
2C-T-4psychedelicresearch chemicalA psychedelic phenethylamine">Phenethylamine that has a longer onset and duration compared to the more common 2C-T-x (2 and 7).
2C-T-7research chemicalempathogenpsychedelicA relatively uncommon psychedelic phenethylamine">Phenethylamine and possible MAOI. Long lasting, an possesses an unpredictable dosage curve. Questionable safety in combination with most things.
3C-Epsychedelicresearch chemicalstimulantThree-Carbon Analog of Escaline. Substituted Amphetamine.
3C-Ppsychedelicstimulantresearch chemicalRather new and uncommon stimulant, psychedelic and Amphetamine with properties similar to the 2Cx class of drugs. 3-carbon homologue of Proscaline.
4-AcO-DALTpsychedelicresearch chemicalAn uncommon tryptamine derivative first reported in the mid 2000s, likely a psychedelic. Little is known about the pharmacology or effects of this compound.
4-AcO-DETtentativepsychedelicresearch chemicalRare drug that is of the tryptamine family, can be comparable to Psilocybin. Expected to quickly hydrolyzed into the free phenolic 4-HO-DET.
4-AcO-DiPTpsychedelicresearch chemicalAn uncommon psychedelic tryptamine with a short history of human use, also known as Ipracetin. Possibly first synthesised by Alexander Shulgin. Some reports of heavy nausea, with effects comparable to 2C-B and Mushrooms.
4-AcO-DMTpsychedelicresearch chemicalcommonA prodrug for Psilocin with extremely similar effects as Mushrooms.
4-AcO-DPTpsychedelictentativeresearch chemicalResearch chemical of the Tryptamine class. First noted being sold in 2012, yet never recieved much attention. Conflicting reports. Doesn't dissolve well at all in nearly all solutions it was tested in.
4-AcO-METpsychedelicresearch chemicalA rare psychedelic tryptamine which is thought to be metabolised into 4-HO-MET. Onset and duration, intensity will vary but effect profile is largely the same.
4-AcO-MiPTtentativepsychedelicempathogenresearch chemicalA quite potent tryptamine that has be related to having "shroom-like" visuals. Yet without much bodyload. Very hydroscopic. Seems to be quite safe in dosing. Similar to the likes of 2C-B.
4-FPPpsychedelicempathogententativestimulantA piperazine derivative that has been reported to have mild pyschedelic effects, and also empathogen qualities. It has been sold in many branded legal highs.
4-HO-DETpsychedelicresearch chemicalA rare compound first produced by Albert Hoffman, also known as ethocin. Structurally related to 4-HO-MET (metocin) and Psilocin (4-HO-DMT), this drug has similar psychedelic effects but little recorded human usage. Probably similar to Mushrooms. Potentially stimulating.
4-HO-DiPTpsychedelicresearch chemicalA psychedelic tryptamine also known as iprocin. A homologue of Psilocin, this drug likely has similar effects to psychedelic Mushrooms. Said to have a rapid onset and relatively short duration for a drug of its class.
4-HO-DPTtentativepsychedelicresearch chemicalA psychedelic hallucinogenic first synthesized by alexander shulgin. At light doses it causes enhanced cognition and appreciation for things like art and music while high doses cause visuals. The drug is known to cause a bodyload.
4-HO-EPTpsychedelictentativeThe 4-Hydroxy version of EPT. Slightly more potent than the prior.
4-HO-MCPTpsychedelictentativeNovel synthetic tryptamine that is the cyclopropyl homologue of Psilocin. Not much is known about anything.
4-HO-METpsychedelicresearch chemicalcommonA lesser known psychedelic tryptamine. Functional analogue of Psilocin. Very poorly soluble in water and Alcohol.
4-HO-MiPTpsychedelicresearch chemicalA reasonably popular tryptamine deriviative and Psilocin analogue, first synthesised by Alexander Shulgin. It has been reported as having comparable effects to psychedelic Mushrooms, though with a shorter duration.
4-HO-MPMIpsychedelicresearch chemicaltentativeA rare tryptamine derivative first synthesised by David Nichols. This drug, also known as lucigenol, has rarely been documented outside the lab. It is known to be a psychedelic similar to other psychoactive tryptamines, with a potency similar to DOI, but little else is known.
4-HO-MPTpsychedelictentativeresearch chemicalPsychedelic drug of the tryptamine class. Higher homologue of Psilocin, and is the 4-hydroxy analogue of N-Methyl-N-Propyltryptamine.
4-MeO-MiPTpsychedelicresearch chemicaltentativeA rare psychedelic tryptamine first synthesised by Alexander Shulgin, said to the be "little brother" of 5-MeO-MiPT. Said to be relatively mild with lighter visual effects than most tryptamines.
5-APBpsychedelicstimulantresearch chemicalempathogenhabit formingA triple monoamine reuptake inhibitor. This agonism for 5-HT2B makes it likely that 5-APB would be cardiotoxic with long term use, as seen in other 5-HT2B agonists such as fenfluramine and MDMA.
5-APDBstimulantpsychedelicresearch chemicalempathogenhabit formingAn entactogenic Amphetamine stimulant with similar structure and effects to MDMA. An analogue of MDA, it is a highly selective serotonin releaser but inhibits reuptake of serotonin (weakly), dopamine and norepinephrine.
5-Bromo-DMTpsychedelictentativeresearch chemicalPsychedelic drug of the Trypyamine class, and is also found in two marine invertebrates. Animal studies have shown that this could be useful for sedative and/or antidepressant use.
5-EAPBstimulantpsychedelicresearch chemicalempathogenhabit formingA empathogen sold as a replacement to 5-MAPB after it was banned in the UK, but said to be less enjoyable and never gained much popularity.
5-IAIstimulantpsychedelicresearch chemicalhabit formingempathogenA monoamine triple releaser first synthesised by David Nichols, possesses similar properties to MDMA. Probably neurotoxic in humans, however the extent of this is unclear.
5-ITstimulantpsychedelicresearch chemicalhabit formingempathogenAn empathogenic stimulant with a very long duration, prone to cause overheating and potentially quite dangerous. Related to αMT, though described as being less psychedelic and with much stronger stimulating effects.
5-MAPBpsychedelicstimulantresearch chemicalempathogenhabit formingAn empathogen structurally similar to MDMA. Typically more visual than MDMA. Often reported to be much less stimulating and more relaxing than most other stimulating empathogens. Less psychedelic than 6-APB. Much longer lasting than MDMA.
5-MAPDBstimulantpsychedelicresearch chemicalempathogenAn entactogenic drug with similar effects to MDMA, it is related to 5-MAPB. Likely to release serotonin and show neurotoxicity in the same way as MDMA
5-MeO-αMTstimulantpsychedelicresearch chemicalempathogenA long-acting psychedelic and entactogenic tryptamine, related to αMT. Very potent and may be sold on blotters. Possibly has been missold as LSD in the past, however this is uncommon. Possibly an MAOI.
5-MeO-DALTpsychedelicresearch chemicalA strange drug with an unknown mechanism of action. Some psychedelic effects alongside some effects non-characteristic of psychedelics like appetite enhancement. Reported as having rapid, intense and short acting entheogenic effects.
5-MeO-DiPTpsychedelicresearch chemicalempathogen5-methoxy-di isopropyl tryptamine, also known as 'foxy', a psychedelic tryptamine related to DMT, which distorts visual and audio perception. Reported to have a heavy body load at high doses, it behaves similarly to other drugs of its class.
5-MeO-DMTpsychedelicresearch chemicalA powerful psychedelic tryptamine found in many species of plants and some toad venom, with a history of use by native South Americans spanning thousands of years. Has similar qualities to DMT and related tryptamines. Very potent. Orally active in combination with an MAOI.
5-MeO-DPTpsychedelicresearch chemicalA rare tryptamine psychedelic and analogue of DPT. Little is known about this compound but it is likely to have effects similar to DPT, DMT and others related compounds.
5-MeO-EiPTpsychedelicresearch chemicaltentativeA little known and little studied tryptamine and analogue of EiPT, also related to DiPT and DET. Probably a psychedelic. Few reports of effects.
5-MeO-MALTpsychedelicresearch chemicalA new and uncommon psychedelic tryptamine related to 5-MeO-DALT. Little is known about it, but its effects are probably similar to other psychedelic tryptamines.
5-MeO-METpsychedelicresearch chemicalAn obscure psychedelic drug similar in structure to 5-MeO-DMT. Possibly first synthesised by Alexander Shulgin. Likely to have similar effects to other tryptamine psychedelics.
5-MeO-MiPTpsychedelicresearch chemicalempathogencommonA potent, stimulating psychedelic tryptamine, sometimes compared to 5-MeO-DiPT. Has an unusually strong body component and weak visual effects. Often said to be very empathogenic.
5-MeO-NIPTpsychedelictentativeresearch chemicalA little known and little studied tryptamine and analogue of NiPT, also related to DiPT and DET. Psychedelic, that is generally regarded as not worth the time.
6-APBstimulantpsychedelicresearch chemicalempathogenhabit formingA stimulant, empathogen and analog of MDA. Typically more visual than MDMA or MDA, as well as having a much longer onset and duration. Users often report a slightly more psychedelic headspace as well. Commonly sold as an alternative to MDMA and MDA.
6-APDBstimulantpsychedelicresearch chemicalempathogenhabit formingA stimulant and entactogen related to MDMA and an analogue of MDA. Reported as being fairly psychedlic at higher doses. It is a triple monoamine reuptake inhibitor. Potent full agonist of serotonin 2B receptors.
6-EAPBstimulantpsychedelicresearch chemicalempathogenhabit formingA rare entactogen benzofuran structurally related to MDMA and 6-APB, though weaker in effects. the pharmacology of this compound is unclear. Likely to be a monoamine releaser, monoamine reuptake inhibitor or both.
6-MAPBstimulantpsychedelicresearch chemicalempathogenhabit formingEmpathogen drug that is structurally related to 6-APB and MDMA.
αETpsychedelicstimulantresearch chemicaltentativeempathogenα-Ethyltryptamine, originally developed by Upjohn as an MAOI antidepressant, this tryptamine is both psychedelic, stimulating and entactogenic. Related to α-MT, briefly popular as an RC in the 1980s but has seen limited use. Similar to αMT, αET is a serotonin releaser and may carry the risk of serotonin syndrome in overdose. Potentially neurotoxic.
AL-LADpsychedelicresearch chemicalAL-LAD is a hallucinogenic drug, lysergamide and an analogue of LSD. It is reported as having some subtle experiential differences to LSD (such as increased visuals), and also appears to be slightly shorter lasting. AL-LAD doses are similar to those of LSD, depending on purity. Its availability on the Internet since 2013 has lead to strong popularity among the drug community.
ALD-52psychedelicresearch chemicaltentativeALD-52, or N-acetyl-LSD is a less common chemical analogue of LSD, first synthesised by Albert Hoffman. It was famously implicated in the 'Orange Sunshine' trial. A psychedelic lysergamide, this compound exhibits similar properties to LSD, and is thought to be a pro-drug for LSD.
Alephpsychedelicempathogenresearch chemicaltentativeThe first sulphur-containing phenethylamine">Phenethylamine to have been evaluated for CNS activity for Stimulant or Psychedelic purposes.
ALEPH-2psychedelicresearch chemicaltentativeA very rare phenethylamine">Phenethylamine, also known as DOT-2, it is the DOx analogue of 2C-T-2. Very little human use recorded. Described as being quite long and highly visual. Likely to be potent, with a reported threshold dose of 3mg.
Allylescalinepsychedelicresearch chemicalMescaline analogue with a much lower dose, that seems to rely heavily on colours.
αMTpsychedelicstimulantresearch chemicalA long-acting psychedelic-empathogen with a broad method of action in the brain. Not suitable for combination with many other substances. Used as an anti-depressant in the Soviet Union, but later found popularity in the RC scene, mainly in the UK.
AyahuascapsychedelicempathogenA concoction made of two or more plants that contain at least an MAOI and DMT, the combination of which allows the DMT to work orally. Typically associated to south american cultures. Also, sometimes approximated synthetically by taking an external MAOI with extracted DMT. Causes intense, spiritually orientated hallucinogenic experiences.
βk-2C-Bpsychedelicresearch chemicalcommonA long-acting psychedelic and empathogen with unpredictable effectiveness. Roughly double the duration of 2C-B. Inactivated by high pH.
βk-2C-Ipsychedelicresearch chemicaltentativeNovel psychedelic that is the Beta-Ketone derivative of 2C-I.
BODpsychedelicresearch chemicaltentativeBeta-methoxy analogue of 2C-D, seems to be more "mild" than the likes of 2C-X and DOX compounds. Is 50/50 whether the body load is barely there, or overpowering the experience.
Bromo-DragonFLYpsychedelicresearch chemicalA psychedelic phenethylamine">Phenethylamine and benzofuran that is very potent and has a long duration. Was briefly sold as "2C-B-FLY" in 2005/6 and has lead to multiple deaths.
Butylonepsychedelicstimulantresearch chemicalhabit formingempathogenEmpathogen and stimulant of the cathinone class.
Cannabisdepressant stimulantpsychedelichabit formingcommonA common and widely used psychoactive plant, which is beginning to enjoy legal status for medical and even recreational use in some parts of the world. Usually smoked or eaten, primary effects are relaxation and an affinity towards food - a state described as being 'stoned.'
ChangapsychedelictentativeChanga is the name given to a smoking blend of caapi or other MAOI containing plants with an infusion of extracted DMT. Changa often contains other milder psychoactive herbs as well. The maoi action results in a longer and more intense trip (see Ayahuasca) NOTE: There is no standardized recipe or concentration of infused DMT, therefor dosage and potency will vary per batch.
CoronaridinepsychedelictentativeAlkaloid found in Tabernanthe iboga and related species. Persistently reduces the self-administration of Cocaine and Morphine in rats.
Cyclopropylmescalinepsychedelictentativeresearch chemicalCyclopropylmescaline, AKA CPM, is a psychedelic/hallucinogenic that was produced by Alexander Shulgin. It causes visual and auditory hallucinations and lasts quite a long time. Little is known about it so caution must be used when trying out this substance.
DALTpsychedelicresearch chemicaltentativePsychedelic drug of the tryptamine class.
DETpsychedelicresearch chemicaltentativeA surprisingly uncommon analogue of DMT with similar effects and reported oral activity without the aid of an MAOI.
Dimemebferesearch chemicalpsychedelicempathogententativeRelated in structure to 5-MeO-DMT, yet much less potent. Described as feeling somewhat similar to Mushrooms, with some empathogenic effects.
DiPTpsychedelicresearch chemicalA rare tryptamine psychedelic closely related to DMT, with the interesting property of having little visual hallucinations, but strong auditory effects.
DMTpsychedeliccommonA popular and powerful psychedelic, typically used in two ways; either it is vapourised for a short 'breakthrough' experience, or it is taken in combination with an enzyme inhibitor for a long, intense trip (this is also known as Ayahuasca or pharmahuasca).
DOBpsychedelicstimulantresearch chemicalDOB is a relatively uncommon synthetic psychedelic. It is best known for its very low doses and long duration. Historically it has rarely been taken deliberately, but in place of LSD, however it has recently found its own place in the research chemical scene.
DOCpsychedelicstimulantresearch chemicalcommonA potent stimulating psychedelic with a long action, a phenethylamine">Phenethylamine and substituted Amphetamine. Sometimes sold as LSD but also enjoyed on its own merits by many. Usually sold on blotters slightly larger than those LSD is found on, but can also be bought in powder form.
DOETpsychedelicresearch chemicaltentativeA potent and long acting psychedelic stimulant and substituted Amphetamine, similar in effects to other DOx compounds. First synthesised by Alexander Shulgin.
DOIpsychedelicstimulantresearch chemicalA potent, long-acting psychedelic stimulant. Historically, it has rarely been consumed deliberately, but occasionally sold as LSD. However, it has recently found its own little nest in the research chemical community.
DOIPtentativepsychedelicstimulantresearch chemicalA rare psychedelic ampthetamine of the same class as the likes of DOM. Is a quite powerful and potent psychedelic that has very strong Amphetamine effects. Not for the faint of heart.
DOMpsychedelicstimulantresearch chemicalcommonThe most popular psychedelic Amphetamine due to its pleasant effects, lower potency and shorter duration. Effects have been described as 'siller' than LSD and related DOX chemicals
DONpsychedelicresearch chemicaltentativeA very rare psychedelic Amphetamine. That is more rough on the body then other DOx compounds. Making it physically painful in some cases.
DOPRpsychedelicresearch chemicaltentativeA rare psychedelic Amphetamine of the same class as DOM. This is a powerful and potent psychedelic with all the effects you would expect from an Amphetamine. Described by Shulgin as a 'heavy duty psychedelic'. Analogue of 2C-P.
DPTpsychedelicresearch chemicalN,N-Dipropyltryptamine, a psychedelic tryptamine compound and lesser-known analogue of DMT, with similar psychedelic effects. Like DMT it is a partial serotonin receptor agonist.
EPTpsychedelictentativeresearch chemicalEthylpropyltryptamine a novel tryptamine, that is the structural homologue of DMT.
Escalinepsychedelicresearch chemicalFirst synthesised in the 50s, this uncommon drug was reexamined by David Nichols in the 1990s. It is an analogue of Mescaline which is roughly six times more potent, and is thus a powerful psychedelic phenethylamine">Phenethylamine. Subjective effects may include stimulation and hallucinations.
ETH-LADresearch chemicalpsychedelicA psychedelic drug and slightly more potent analogue of LSD, first synthesised by Alexander Shulgin - sometimes described as being less 'abrasive' than LSD. Less common than the associated AL-LAD, though has seen some popularity since its release on the Internet research chemical scene in 2015.
Ethylcathinonestimulantpsychedelicresearch chemicalhabit formingEthylcathinone is a synthetic stimulant. It is similar to ecstasy in the sense that it provides euphoria, feelings of empathy and openness, and a desire to talk with others. It also carries over to some of the negative effects of ecstasy, such as insomnia, tightened jaw muscles, and grinding of the teeth.
Ethylonestimulantpsychedelicresearch chemicalhabit formingempathogenA euphoric stimulant often sold in place of MDMA since Methylone was banned. Slightly less potent and empathogenic than Methylone, it is often described as more of a 'straight stimulant.'
HOT-2psychedelicresearch chemicaltentativeA rather rare psychedelic phenylethylamine that is the hydroxylated version and prodrug for 2C-T-2.
HOT-7psychedelicresearch chemicaltentativeempathogenA rather rare psychedelic phenylethylamine that is the hydroxylated version and prodrug for 2C-T-7.
Ibogainepsychedelicopioiddissociativedepressant An alkaloid found in many African plants most famously Iboga, with psychedelic and hallucinogenic properties. May be unpleasant. Traditionally used in tribal environments for coming-of-age rituals, it has recently been used as an alternative treatment for drug addiction although this usage has not been backed by conclusive data in humans. Has killed in overdose.
Indapexpsychedelicresearch chemicaltentative5-MEO-TMT, one of Shulgin's lesser known creations. A psychedelic tryptamine little heard of outside of TiHKaL with very little known information about its effects on humans. May be particularly given to causing nausea.
Isoproscalinepsychedelicresearch chemicaltentativeA analogue of Mescaline, and more closely related to Proscaline.
LSApsychedeliccommonA chemical found in Morning Glory and Hawaiian Baby Woodrose seeds, which are often legally available. Has mental effects similar to LSD, although with almost no visual effects. It is famous for being very nauseating, and for causing excessive time dilation at higher doses.
LSDpsychedeliccommonLSD is a popular psychedelic with a relatively long history of use and research, and as such is known to be relatively safe despite its extremely high potency. It is the archetypical psychedelic to which all others are compared, and remains in popular usage.
LSM-775psychedelicresearch chemicaltentativePsychedelic of the lysergamide class, less potent by weight and produces a rather mild, dreamy and even sedating trip compared to its bigger brother LSD.
LSZpsychedelicresearch chemicalA lysergamide very similar to LSD usually distinguishable only by its shorter duration, though some subjective reports have noted it may be slightly more introspective and slightly less confusing.
MDApsychedelicstimulantempathogenhabit formingcommonA stimulant and empathogen. Similar to MDMA but typically produces more visuals than MDMA. Known to be more neurotoxic than MDMA, and is a minor metabolite of MDMA. Duration and onset similar to MDMA. The common Marquis reagent test cannot differentiate MDA and MDMA.
MDAIpsychedelicstimulantresearch chemicalhabit formingempathogenA selective serotonin releasing agent which is rarely used without a stimulant to gain desirable effects. Not believed to be neurotoxic.
MDMAstimulantpsychedelicempathogenhabit formingcommonThe world's most popular empathogen with powerful pro-social effects. Has been strongly linked to cognitive decline in excess. Popular at parties, it is often sold in powder or in pills, and may be adulterated with other similar chemicals.
MDOHstimulantpsychedelicresearch chemicaltentativeempathogenhabit formingAn entactogen, stimulant and psychedelic first synthesised by Alexander Shulgin, MDOH is an analogue of MDA. Described as highly psychedelic, it is likely a serotonin releasing agent. It has not seen widespread use, perhaps due to a number of reported negative side effects such as urinary retention and a heavy comedown.
MEMpsychedelicresearch chemicaltentativeA rare stimulant, psychedelic and Amphetamine discovered by Alexander Shulgin. Related to the DOx class of drugs, little is known about this obscure compound's pharmacology, however it is likely to be potent and have a long duration.
MescalinepsychedeliccommonA psychedelic of the phenethylamine">Phenethylamine family. Found in psychedelic cacti that have long been used by peoples native to the Southwestern US and Mexico, including Peyote and San Pedro cacti, among others. Can be found as cactus pulp, as an extract from cacti, or as a synthetic substance created in a lab.
METpsychedelicresearch chemicaltentativeA rare psychedelic tryptamine, related to DMT and DET. Little information exists about the effects or pharmacology of this drug.
Methallylescalinepsychedelicresearch chemicalMescaline analogue first synthesised by Alexander Shulgin, derived from and less potent than Allylescaline. A psychedelic phenethylamine">Phenethylamine which causes stimulation, euphoria and hallucinatory experiences.
Methamnetaminepsychedelicstimulantresearch chemicaltentativeempathogenhabit formingA selective serotonin releaser, which also shows some light psychedelic activity. Almost always taken with a stimulant, to cause euphoric effects.
Methylonestimulantpsychedelicresearch chemicalhabit formingempathogencommonβk-MDMA is a cathinone stimulant and empathogen, similar in structure to MDMA, though more stimulating and less empathogenic in comparison. Was very commonly mis-sold as MDMA on the street until it was banned in 2013. The Marquis reagent can differentiate βk-MDMA from MDMA. Less potent than MDMA with a slightly shorter duration.
Mexaminepsychedelictentative5-Methoxytryptamine, a tryptamine derivative that naturally occurs in the body at low levels. No evidence of recreational use. Apparently enhances dreams.
MiPTpsychedelicresearch chemicaltentativeN-Methyl-N-isopropyltryptamine, a tryptamine analogue of DMT, a very uncommon drug with very few reports of human use. Described as 'more psychedelic than hallucinogenic' users report only mild visuals with some stimulation and cognitive effects. One of the more stable tryptamines.
MushroomspsychedeliccommonFungi containing psilocybin, a prototypical psychedelic with similar effects to LSD, but with a shorter duration; also considered as being more confusing, introspective and entheogenic. Usually refers to psilocybe Mushrooms rather than Amanitas, which have different effects. Are considered physically safe if properly identified, which should always be done by an expert.
Pentylonestimulantpsychedelicresearch chemicalhabit formingA stimulant, empathogen and substituted cathinone. It was first synthesised in the 1960s, and re-appeared on the research chemical scene in 2010. Still, very little is known about the pharmacology or effects of this compound.
PeyotepsychedeliccommonPeyote is a small, spineless cactus that contains Mescaline as its primary active chemical. It has a long history of use among the natives of northern Mexico and SW United States.
PiPTpsychedelicresearch chemicaltentativeA rare psychedelic tryptamine related to DPT. Little is known about the effects or safety profile of this compound.
PRO-LADtentativepsychedelicA very rare lysergamide that is slightly less potent than LSD, yet with a shorter duration of action.
Proscalinepsychedelicresearch chemicalA very uncommon psychedelic stimulant and phenethylamine">Phenethylamine and analogue on Mescaline with similar effects. Roughly 5-7 times more potent than Mescaline by weight.
Psilocinpsychedelictentativeempathogenresearch chemicalPsilocin is a substutued tryptamine alkaloid, that is present in most psychedelic Mushrooms. It is relatively unstable in solution due to the -OH group.
SinicuichipsychedelictentativeA perennial shrub with small narrow leaves and yellow flowers growing up to ~1.5 meters. Known under many different names. Has been used for Shamanic purposes by natives in Central America and Mexico. Mostly auditory based.
TMA-2psychedelicresearch chemicaltentativeTrimethoxyamphetamine-2, a psychedelic Amphetamine and stimulant first synthesised by Alexander Shulgin. An uncommon compound of similar activity to other psychedelic amphetamines. Short history of human use.
TMA-6psychedelicresearch chemicaltentativeA rarely seen Psychedelic Amphetamine and Mescaline analogue. First synthesised by Alexander Shulgin, who descrived it as "one of the most rewarding and pleasurable of the methoxylated amphetamines."
TrufflespsychedelicTruffles (magic Truffles, sclerotium) are the thickened root sections of magic Mushrooms. Like magic Mushrooms, Truffles contain the psycho-active chemicals psilocybin and Psilocin. See Mushrooms for more information.
YOPOempathogenpsychedelicAnadenanthera peregrina, also known as YOPO, is a perennial tree native to the Caribbean and South America. It is an entheogen containing 5-MeO-DMT and DMT, and is used in healing ceremonies and rituals. It is also a source of dietary calcium.
βH-2C-Bpsychedelicresearch chemicaltentativeβ-Hydroxy-2C-B is a novel analogue of 2C-B that is a bit less potent and has a longer duration. It's thought to be the active metabolite of βk-2C-B.

Factsheets on 148 drugs